Incannex Healthcare (IXHL) Current Deferred Revenue (2021 - 2026)

Incannex Healthcare (IXHL) has reported Current Deferred Revenue for 6 consecutive years, with $30000.0 the latest figure, recorded in Q1 2026.

• Quarterly Current Deferred Revenue rose 7.14% year-over-year to $30000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $30000.0 (up 7.14% YoY) and the FY2025 annual result came in at $30000.0, down 64.71% from the prior year.
• Current Deferred Revenue was little changed at $30000.0 in Q1 2026 per IXHL's latest filing, from $30000.0 in the prior quarter.
• Over the last five years, Current Deferred Revenue for IXHL reached as high as $3.7 million in Q2 2023 and fell as low as $27000.0 in Q4 2024.
• A 5-year average of $582261.7 and a median of $30000.0 in 2025 frame the typical range for Current Deferred Revenue.
• Annual changes were most pronounced in 2022 — Current Deferred Revenue surged 197.4% — and 2024, when it sank 97.69%.
• Year by year, Current Deferred Revenue stood at $1.8 million in 2022, then soared by 100.99% to $3.7 million in 2023, then plunged by 99.27% to $27000.0 in 2024, then climbed by 11.11% to $30000.0 in 2025, then changed by 0.0% to $30000.0 in 2026.
• According to Business Quant data, Current Deferred Revenue over the past three periods registered $30000.0, $30000.0, and $30000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.